Featured Research

from universities, journals, and other organizations

Improving the lives of allergy sufferers

Date:
September 10, 2013
Source:
BioMed Central Limited
Summary:
Allergen immunotherapy improves the quality of life of people who are allergic to grass pollen and house dust mites, reveals a new study. With less time taken off work, the therapy yields economic as well as patient benefits.

Allergen immunotherapy improves the quality of life of people who are allergic to grass pollen and house dust mites, reveals a study in the open access World Allergy Journal. With less time taken off work, the therapy yields economic as well as patient benefits.

Around a quarter of adults in Europe suffer from respiratory allergies. Symptoms can include asthma and / or rhino-conjunctivitis, inflammation of the inner nasal lining which causes a runny, stuffy nose. Treatment is usually with drugs, such as antihistamines, which manage the symptoms.

Allergen immunotherapy, however, seeks to treat the underlying cause. Subcutaneous immunotherapy, the type used in this study, involves regular injections with increasing doses of a specific allergen vaccine, then less frequent 'top-up' injections over several years.

Karin D Petersen and colleagues observed 248 allergy patients prospectively as they received the treatment for one year. As expected, disease severity lessened, but critically, this translated to significant improvements in quality of life. Sufferers experienced fewer symptom-filled days -- 145 instead of 189 days per year -- and took fewer sick days from work -- 1.2 instead of 3.7.

This is likely to have knock-on effects for patients, employers and society, the team say. One US study found that allergic rhino-conjunctivitis causes an annual at-work productivity loss of around $2.5 billion. A separate study showed employees with allergic rhino-conjunctivitis suffer a productivity loss of around $593 per year.

But the real burden is personal, an element that is difficult to measure using traditional methods. Clinical symptoms, for example, correlate only modestly with everyday functional capabilities and patients' perceptions of their condition. The methods used in this study successfully measure personal quality of life as well as disease severity, highlighting the clinical and personal benefits to be gained from subcutaneous allergen immunotherapy.


Story Source:

The above story is based on materials provided by BioMed Central Limited. Note: Materials may be edited for content and length.


Journal Reference:

  1. Karin D Petersen, Christian Kronborg, Jψrgen N Larsen, Ronald Dahl, Dorte Gyrd-Hansen. Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days. World Allergy Organization Journal, 2013; 6 (1): 15 DOI: 10.1186/1939-4551-6-15

Cite This Page:

BioMed Central Limited. "Improving the lives of allergy sufferers." ScienceDaily. ScienceDaily, 10 September 2013. <www.sciencedaily.com/releases/2013/09/130910205324.htm>.
BioMed Central Limited. (2013, September 10). Improving the lives of allergy sufferers. ScienceDaily. Retrieved August 30, 2014 from www.sciencedaily.com/releases/2013/09/130910205324.htm
BioMed Central Limited. "Improving the lives of allergy sufferers." ScienceDaily. www.sciencedaily.com/releases/2013/09/130910205324.htm (accessed August 30, 2014).

Share This




More Health & Medicine News

Saturday, August 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) — A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) — Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) — California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
3 Things To Know About The Ebola Outbreak's Progression

3 Things To Know About The Ebola Outbreak's Progression

Newsy (Aug. 29, 2014) — Here are three things you need to know about the deadly Ebola outbreak's progression this week. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins